18F-FDG PET/CT helps rule out malignancy in lipomatous hypertrophy of the interatrial septum with atypical MRI manifestations, to avoid unnecessary surgical treatment.

MLA

Du, Yaqi, et al. “18F-FDG PET/CT Helps Rule out Malignancy in Lipomatous Hypertrophy of the Interatrial Septum with Atypical MRI Manifestations, to Avoid Unnecessary Surgical Treatment.” The International Journal of Cardiovascular Imaging, vol. 38, no. 9, Sept. 2022, pp. 2089–92. EBSCOhost, https://doi.org/10.1007/s10554-022-02632-w.

APA

Du, Y., Li, C., Chen, S., Zhong, Y., Yu, S., & Wang, G. (2022). 18F-FDG PET/CT helps rule out malignancy in lipomatous hypertrophy of the interatrial septum with atypical MRI manifestations, to avoid unnecessary surgical treatment. The International Journal of Cardiovascular Imaging, 38(9), 2089–2092. https://doi.org/10.1007/s10554-022-02632-w

Chicago

Du, Yaqi, Ce Li, Song Chen, Ying Zhong, Shimeng Yu, and Guan Wang. 2022. “18F-FDG PET/CT Helps Rule out Malignancy in Lipomatous Hypertrophy of the Interatrial Septum with Atypical MRI Manifestations, to Avoid Unnecessary Surgical Treatment.” The International Journal of Cardiovascular Imaging 38 (9): 2089–92. doi:10.1007/s10554-022-02632-w.